Liu, Dan
Xu, Zefeng
Zhang, Peihong
Qin, Tiejun
Li, Bing
Qu, Shiqiang
Pan, Lijuan
Cai, Wenyu http://orcid.org/0000-0002-7550-8832
Liu, Jinqin
Wang, Huijun
Sun, Qi
Sun, Xiujuan
Jiao, Meng
Gao, Qingyan
Shi, Zhongxun
Huang, Huijun
Huang, Gang http://orcid.org/0000-0002-5457-5358
Gale, Robert Peter
Xiao, Zhijian http://orcid.org/0000-0002-1099-4489
Article History
Received: 2 July 2021
Revised: 8 September 2021
Accepted: 8 September 2021
First Online: 17 September 2021
Competing interests
: RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc., and CStone Pharmaceuticals; advisor to Antegene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. There was no competing interest of other authors.